Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (311-320 of 367) with videos related to

Pageof 37
Sort By:
International Journal of Cancer|November 10, 2018
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trialDarrel A Cook, Mel Krajden, Adam R Brentnall, et al.
The Lancet. Oncology|September 12, 2008
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trialFrancesca Carozzi, Massimo Confortini, Paolo Dalla Palma, et al.
Breast Cancer Research and Treatment|February 25, 2016
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and managementIan M Collins, Adrian Bickerstaffe, Thilina Ranaweera, et al.
BMC Public Health|January 27, 2018
Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UKD Gareth Evans, Adam R Brentnall, Michelle Harvie, et al.
Journal of the National Cancer Institute|June 8, 2006
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trialGuglielmo Ronco, Nereo Segnan, Paolo Giorgi-Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifenMitch Dowsett, Jack Cuzick, Jim Ingle, et al.
Breast Cancer Research and Treatment|April 4, 2019
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variantsD Gareth R Evans, Elaine F Harkness, Adam R Brentnall, et al.
Disease Markers|June 23, 2011
Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencingNataša Vasiljević, Keqiang Wu, Adam R Brentnall, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 15, 2022
Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panelD Gareth R Evans, Elke M van Veen, Elaine F Harkness, et al.
Trials|August 1, 2019
Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trialAmy Brenner, Adefemi Afolabi, Syed Masroor Ahmad, et al.
Pageof 37

Showing results (311-320 of 367) with videos related to

Sort By:
Pageof 37
International Journal of Cancer|November 10, 2018
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trialDarrel A Cook, Mel Krajden, Adam R Brentnall, et al.
The Lancet. Oncology|September 12, 2008
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trialFrancesca Carozzi, Massimo Confortini, Paolo Dalla Palma, et al.
Breast Cancer Research and Treatment|February 25, 2016
iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and managementIan M Collins, Adrian Bickerstaffe, Thilina Ranaweera, et al.
BMC Public Health|January 27, 2018
Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UKD Gareth Evans, Adam R Brentnall, Michelle Harvie, et al.
Journal of the National Cancer Institute|June 8, 2006
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trialGuglielmo Ronco, Nereo Segnan, Paolo Giorgi-Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifenMitch Dowsett, Jack Cuzick, Jim Ingle, et al.
Breast Cancer Research and Treatment|April 4, 2019
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variantsD Gareth R Evans, Elaine F Harkness, Adam R Brentnall, et al.
Disease Markers|June 23, 2011
Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencingNataša Vasiljević, Keqiang Wu, Adam R Brentnall, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 15, 2022
Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panelD Gareth R Evans, Elke M van Veen, Elaine F Harkness, et al.
Trials|August 1, 2019
Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trialAmy Brenner, Adefemi Afolabi, Syed Masroor Ahmad, et al.
Pageof 37